Skip to main content
. 2021 Oct 14;12:747140. doi: 10.3389/fmicb.2021.747140

FIGURE 2.

FIGURE 2

Schematic of the gold nanoparticle-based LFB for N. gonorrhoeae-MCDA product visualization. (A) MCDA products (0.5 μl) and running buffer (100 μl) were deposited on the sample pad. (B) The running buffer containing MCDA products moves along the LFB due to capillary action, while streptavidin dye-coated gold nanoparticles (streptavidin-DPNs) are rehydrated in the conjugate region. (C) For positive samples, FAM/biotin-labeled orf1-MCDA amplicons are captured by anti-carboxyfluorescein (FAM) at the test line (TL), and streptavidin-DPNs are captured by biotin-BSA at the control line (CL). For negative outcomes, only streptavidin-DPNs are captured by biotinylated bovine serum albumin (biotin-BSA) at the CL. (D) Interpretation of N. gonorrhoeae-MCDA-LFB assay results; positive – CL and TL appear on the LFB, and negative – only the CL appears on the LFB.